EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 42 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,009,990 | +1.8% | 99,999 | 0.0% | 0.01% | +11.1% |
| Q3 2022 | $992,000 | +1.4% | 99,999 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $978,000 | +0.4% | 99,999 | 0.0% | 0.01% | -46.2% |
| Q1 2022 | $974,000 | +0.5% | 99,999 | 0.0% | 0.01% | +30.0% |
| Q4 2021 | $969,000 | +0.2% | 99,999 | 0.0% | 0.01% | -23.1% |
| Q3 2021 | $967,000 | +0.1% | 99,999 | 0.0% | 0.01% | +8.3% |
| Q2 2021 | $966,000 | – | 99,999 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |